These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20965681)

  • 1. In vitro influence of fatty acids and bilirubin on binding of mycophenolic acid to human serum albumin.
    Vial Y; Tod M; Hornecker M; Urien S; Conti F; Dauphin A; Calmus Y; Blanchet B
    J Pharm Biomed Anal; 2011 Feb; 54(3):607-9. PubMed ID: 20965681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of unbound mycophenolic acid concentrations in patients after hematopoietic cell transplantation.
    Huang J; Jacobson P; Brundage R
    Ther Drug Monit; 2007 Aug; 29(4):385-90. PubMed ID: 17667790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
    Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Shaw LM; Mathot RA
    Clin Pharmacokinet; 2009; 48(7):463-76. PubMed ID: 19691368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics analysis of mycophenolic acid in adult kidney transplant patients with chronic graft dysfunction.
    Guillet BA; Simon NS; Purgus R; Botta C; Morange S; Berland Y; Pisano PS
    Ther Drug Monit; 2010 Aug; 32(4):427-32. PubMed ID: 20592648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
    Kuypers DR; Naesens M; Vermeire S; Vanrenterghem Y
    Clin Pharmacol Ther; 2005 Oct; 78(4):351-61. PubMed ID: 16198654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly imprinted solid-phase extraction for rapid screening of mycophenolic acid in human plasma.
    Yin J; Wang S; Yang G; Yang G; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 844(1):142-7. PubMed ID: 16891160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of fatty acids on the binding of bilirubin to albumin.
    Odell GB; Cukier JO; Ostrea EM; Maglalang AC; Poland RL
    J Lab Clin Med; 1977 Feb; 89(2):295-307. PubMed ID: 833468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo binding of the immunosuppressant mycophenolic acid to dog and cat plasma proteins and the effect of co-incubated dexamethasone and prednisolone.
    Morassi A; Rivera-Vélez SM; Slovak JE; Court MH; Villarino NF
    J Vet Pharmacol Ther; 2018 Aug; 41(4):513-521. PubMed ID: 29687456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopy study and co-administration effect on the interaction of mycophenolic acid and human serum albumin.
    Ma X; Yan J; Wang Q; Wu D; Li H
    Int J Biol Macromol; 2015; 77():280-6. PubMed ID: 25841376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of serum albumin affinity for aspirin induced by fatty acid.
    Bojko B; Sułkowska A; Maciazek M; Równicka J; Njau F; Sułkowski WW
    Int J Biol Macromol; 2008 May; 42(4):314-23. PubMed ID: 18346781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid enhancement of the quantum yield for the formation of lumirubin from bilirubin bound to human albumin.
    Malhotra V; Greenberg JW; Dunn LL; Ennever JF
    Pediatr Res; 1987 Jun; 21(6):530-3. PubMed ID: 3601472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients.
    Mandla R; Midtvedt K; Line PD; Hartmann A; Bergan S
    Transpl Int; 2006 Jan; 19(1):44-53. PubMed ID: 16359376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood distribution of mycophenolic acid.
    Langman LJ; LeGatt DF; Yatscoff RW
    Ther Drug Monit; 1994 Dec; 16(6):602-7. PubMed ID: 7878701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MPA and MPAG removal by continuous venovenous hemodiafiltration and continuous venovenous hemofiltration.
    Cussonneau X; Bolon-Larger M; Prunet-Spano C; Bastien O; Boulieu R
    Ther Drug Monit; 2008 Feb; 30(1):100-2. PubMed ID: 18223470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.